The future is upon us, page-17

The applications for RAP are so obvious.

I was also reading the Telehealth diagnosis (in general not specifically the below company) of respiratory conditions is good already but not great. So what happens is that the physician then must choose a broad spectrum medication - as they don't know exactly what the condition is. This can lead to resistance of the medication from the body.

However, once these type of Telehealth companies use ResApp, the diagnosis will be much more specific and medication is more targeted. Interesting times ahead.

The exciting thing is we know the CEO is already looking to partner with Telehealth providers, just a matter of time before the announcements flow IMO.